Le Lézard
Classified in: Health
Subject: FEA

Essity named diversity leader among European companies


STOCKHOLM, Nov. 17, 2021 /PRNewswire/ -- The hygiene and health company Essity has been designated a Diversity Leader by the UK business daily Financial Times. In the newspaper's annual ranking of diversity work in the business sector in 15 European countries, Essity was ranked 25th out of 15,000 companies. 

The survey, carried out by the Statista research firm on behalf of the Financial Times, asked more than 100,000 employees in European companies to appraise the extent to which they perceive that their employer promotes diversity. The respondents also answered questions about and considered statements on age, gender, equality, ethnicity, disability and sexual orientation (HBTQ+).

Of the 15,000 European companies included in the survey, the top 850 were presented and Essity was ranked 1st in its industry and 25th overall.

"Diversity and inclusion are business critical since this provides a broader recruitment base, which leads to better decision-making in the business and thereby better results. Essity works purposefully with these issues. Therefore, it's particularly gratifying to be recognized as one of the leading employers in Europe," says Magnus Groth, Essity's President and CEO.

Read more about Financial Times Diversity Leader ranking here

CONTACT:

For further information, please contact:
Henrik Sjöström, Media Relations Manager, +46 8 788 51 36, [email protected] 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/essity/r/essity-named-diversity-leader-among-european-companies,c3455327

The following files are available for download:

https://mb.cision.com/Main/15798/3455327/1497504.pdf

Essity named diversity leader among European companies

https://news.cision.com/essity/i/ft-leaderdiversity-2021-siegel-rgb-singular,c2980830

FT LeaderDiversity 2021 Siegel RGB Singular

SOURCE Essity


These press releases may also interest you

at 12:59
More than 400 members of the myasthenia gravis (MG) rare disease community will come together this week at the MGFA National Patient Conference for support and a better understanding of how to manage their disease while learning about the latest...

at 12:36
Kedrion Biopharma Inc., an international biopharmaceutical company specializing in the research and development, production, and commercialization of plasma-derived therapeutic products used in treating rare and serious diseases, announced today that...

at 12:28
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, today announced it was selected by X4 Pharmaceuticals, Inc. for the distribution of XOLREMDItm (mavorixafor), recently approved by the U.S....

at 12:20
Soleo Health, a national provider of complex specialty pharmacy services, announced today the opening of its latest pharmacy and ambulatory infusion center (AIC) in Ridgeland, Mississippi. Soleo Health Jackson offers a broad range of specialty...

at 12:08
Prices have gone up?and stayed up?since the pandemic, but Eyemart Express has bucked this consumer pricing trend by keeping its prescription eyewear affordable. Since its founding in 1990, the national optical retailer has remained committed to...

at 12:05
Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic...



News published on and distributed by: